Novel and Expanded Oncology Drug Approvals of 2016 —PART 1: New Options in Solid Tumor Management

This article focuses on the new agents and indications that emerged in 2016 for solid tumor treatment. We review the drug indications, mechanisms of action, pivotal trial data, pertinent toxicities, use in special populations, and the appropriate clinical contexts for treatment planning.

Source: CancerNetwork - February 15, 2017 Category: Cancer & Oncology Authors: Christine M. Walko, PharmD, BCOP James Saller, MD Todd C. Knepper, PharmD Tags: Oncology Journal Review Article Source Type: news